Telesis Bio earnings missed by $0.07, revenue fell short of estimates

  • Investing.com
Telesis Bio earnings missed by $0.07, revenue fell short of estimates
Credit: © Reuters.

Investing.com - Telesis Bio (NASDAQ: TBIO ) reported third quarter EPS of $-0.37, $0.07 worse than the analyst estimate of $-0.30. Revenue for the quarter came in at $5.6M versus the consensus estimate of $7.4M.

Telesis Bio's stock price closed at $0.50. It is down -58.37% in the last 3 months and down -68.75% in the last 12 months.

Telesis Bio saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Telesis Bio's stock price’s past reactions to earnings here.

According to InvestingPro, Telesis Bio's Financial Health score is "great performance".

Check out Telesis Bio's recent earnings performance , and Telesis Bio's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100